Similarly, a biomarker substudy [24] of the PROVE-HF trial, which included 111 patients with longitudinal analysis of ANP levels confirmed an early and sustained increase in ANP after initiation of sacubitril/valsartan therapy. Here, NPPA is linked to hydrops fetalis.